Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Pipelines
Anti-TB
Biologics
Host Directed
Clinical HDT Pipeline
Trials for Market Approval
Download PPT
Advancing
Either
No
Yes
Marketed
On
NCE
On
Repurposed
On
Trials for Market Approval
On
Phase 2
Metformin
Imatinib
Phase 2: IMPACT-TB Safety, Pharmacokinetics & Hematologic Effect of Imatinib
Pravastatin
NIAID, NIH, DHHS
Phase 2b: StAT-TB (Statin Adjunctive Therapy for TB)
Auranofin
The Aurum Institute NPC, Calibr, The Scripps Research Institute
Phase 2 Safety, Efficacy & Biomarker Response of HDTs Added to Standard Therapy